Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (781-790 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2019
Computer-assisted prediction of clinical progression in the earliest stages of ADHanneke F M Rhodius-Meester, Hilkka Liedes, Juha Koikkalainen, et al.
Journal of the American Geriatrics Society|December 23, 2011
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease studySietske A M Sikkes, Pieter Jelle Visser, Dirk L Knol, et al.
European Journal of Neurology|June 24, 2025
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMSIngrid S van Maurik, Daniele Altomare, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individualsGemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 28, 2017
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designArno de Wilde, Ingrid S van Maurik, Marleen Kunneman, et al.
Clinical Proteomics|December 7, 2018
The plasma peptidomeJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Biomarker Research|September 27, 2025
Bridging the barrier: insights into blood biomarkers and therapeutic strategies targeting choroid plexus and BBB dysfunction in alzheimer's diseaseNiti Sharma, Danyeong Kim, Himadri Sharma, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Pageof 91

Showing results (781-790 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2019
Computer-assisted prediction of clinical progression in the earliest stages of ADHanneke F M Rhodius-Meester, Hilkka Liedes, Juha Koikkalainen, et al.
Journal of the American Geriatrics Society|December 23, 2011
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease studySietske A M Sikkes, Pieter Jelle Visser, Dirk L Knol, et al.
European Journal of Neurology|June 24, 2025
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMSIngrid S van Maurik, Daniele Altomare, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individualsGemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 28, 2017
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designArno de Wilde, Ingrid S van Maurik, Marleen Kunneman, et al.
Clinical Proteomics|December 7, 2018
The plasma peptidomeJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Biomarker Research|September 27, 2025
Bridging the barrier: insights into blood biomarkers and therapeutic strategies targeting choroid plexus and BBB dysfunction in alzheimer's diseaseNiti Sharma, Danyeong Kim, Himadri Sharma, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Pageof 91